NCT02810509

Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,814 (actual)
• Sponsor: Inje University · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The current study aims to assess the quality of anticoagulation with warfarin in real world practice of secondary stroke prevention in Korean patients with Atrial fibrillation (AF) and to explore predictors for poor International Normalized Range (INR) control.

Detailed description

* To assess the quality of anticoagulation with warfarin in real world practice of Korea for secondary stroke prevention in patients with AF-related Cardioembolic (CE) stroke 1) who initiated warfarin therapy and treatment at least for more than 7 days of warfarin adjustment period (warfarin-initiated cohort), and 2) who initiated and maintained warfarin therapy at least for more than 90 days after the 7 days of warfarin adjustment period (long-term warfarin-treated cohort). * To explore predictors for poor INR control.

Conditions

• Atrial Fibrillation
• Stroke

Timeline

• Start date: 2015-06-01
• Primary completion: 2016-10-01
• Completion: 2016-10-01
• First posted: 2016-06-23
• Last updated: 2019-09-13
• Results posted: 2019-09-13

Locations

18 sites across 1 country: South Korea